New York would allocate $750 million to build over 50,000 charging stations and other electric-vehicle infrastructure.
On Thursday, Governor Andrew Cuomo announced the investment program to be funded by the state’s investor-owned utility companies with a budget capped at $701 million through 2025.
An additional $48.8 million would come from a 2017 settlement with German carmaker Volkswagen AG over its diesel emissions cheating scandal.
The investment is part of the state’s long-term goal to reduce emissions.
Florida announced a similar measure of investing $8.6 million to expand charging stations on July 10.
Electric vehicle sales in the US have increased over the past years, although they still made up less than two percent of all vehicle sales in the country last year.
Factors putting off consumers from buying electric cars is the high sticker price and limited charging infrastructure.


Samsung Reports Record Profit as AI Boom Drives Memory Chip Demand
Seagate Stock Surges After Strong Q3 Earnings Beat and Bullish Outlook
Pershing Square Raises $5 Billion in Landmark U.S. IPO and Share Placement
Air Liquide Q1 Revenue Misses Estimates Amid Currency and Energy Headwinds
Novartis Q1 2026 Earnings Miss Expectations as Generic Competition Pressures Sales
Coles Group Q3 Sales Rise Driven by Supermarkets and E-Commerce Growth
GameStop Eyes eBay Acquisition as Stock Prices Surge After Hours
Standard Chartered Q1 Profit Hits Record on Wealth and Investment Banking Growth
Amazon Stock Dips Despite Record Earnings as AI Infrastructure Spending Surges
Ford Q1 Earnings Beat Expectations, Stock Surges on Strong Guidance
Microsoft Azure Growth Forecast Beats Expectations Amid Rising AI Competition
U.S. Cybersecurity Pushes Faster Patch Deadlines Amid Rising AI-Driven Threats
Meta Raises 2026 Capex Outlook Amid AI Spending Surge, Shares Drop After Earnings
T-Mobile Beats Q1 Earnings Expectations on Strong Postpaid Growth
Google Secures Pentagon AI Deal for Classified Projects
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales 



